• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

EFPIA Appoints Interim Director General


December 12, 2016

  The European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced that Eric Cornut has been appointed Interim Director General as Richard Bergström leaves the organization after five years at the helm.   Mr. Cornut has held roles including at Novartis, including Head of Europe, Chief Commercial Officer, and most recently Chief Ethics, Compliance and Policy Officer, and he led the EFPIA Executive Committee from 2008 to 2013. He is currently an independent consultant.   Mr. Cornut commented: “2017 will be a critical year for the industry, with major milestones including the reviews of key legislations and the Commission’s Roadmap on HTA cooperation in Europe. I look forward to working with the EFPIA Board and the team on this important agenda.”            

Related Videos